Cargando…
Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial
BACKGROUND: Buruli Ulcer (BU) is a tropical infectious skin disease that is currently treated with 8 weeks of intramuscular streptomycin and oral rifampicin. As prolonged streptomycin administration can cause both oto- and nephrotoxicity, we evaluated its long term toxicity by following-up former BU...
Autores principales: | Klis, Sandor, Stienstra, Ymkje, Phillips, Richard O., Abass, Kabiru Mohammed, Tuah, Wilson, van der Werf, Tjip S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953024/ https://www.ncbi.nlm.nih.gov/pubmed/24625583 http://dx.doi.org/10.1371/journal.pntd.0002739 |
Ejemplares similares
-
Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions: Long-Term Follow-up of the BURULICO Trial
por: Klis, Sandor, et al.
Publicado: (2014) -
Wound Care in Buruli Ulcer Disease in Ghana and Benin
por: Velding, Kristien, et al.
Publicado: (2014) -
Former Buruli Ulcer Patients’ Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
por: Velink, Anita, et al.
Publicado: (2016) -
Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
por: Barogui, Yves Thierry, et al.
Publicado: (2016) -
Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)